Health-related quality of life: A primer for gastroenterologists

American Journal of Gastroenterology

Volumn 94, Issue 8, 1999, Pages 2017-2021

  Eisen, Glenn M ^a,c   Richard Locke, G ^b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b MAYO CLINIC   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PRACTICE; DECISION MAKING; PERCEPTION; PRIORITY JOURNAL; PSYCHOMETRY; QUALITY OF LIFE; RELIABILITY; REVIEW;

GASTROINTESTINAL DISEASES; HUMANS; PSYCHOMETRICS; QUALITY OF LIFE; SICK ROLE; SICKNESS IMPACT PROFILE; TREATMENT OUTCOME;

EID: 0033180379     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1999.01272.x     Document Type: Review

References (17)

1. Testa MA, Simonson DC. Assessment of quality of life outcomes. N Engl J Med 1996;334:835-40.
2. Karnofsky DA, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. In: Maclead CM, ed. Evalu-ation of chemotherapeutic agents. New York: Columbia University Press, 1947:37-56.
3. Constitution of the World Health Organization. World Health Organization. Handbook of basic documents, 5th ed. Geneva: Palais des Nations, 1952.
4. Shumaker SA, Anderson RT, Czajkowski SM. Psychological test and scales. In: Spilker B, ed. Quality of life assessment in clinical trials. New York: Raven Press, 1990:272-91.
5. Kirshner B, Guyatt GH. A methodological framework for assessing health indices. J Chron Dis 1988;38:27-36.
6. Drossman DA. Quality of life in IBD: Methods and findings. In: Rachmeilewitz D, ed. 72nd Falk Symposium (Strasbourg, France), inflammatory bowel disease-1994. Dordrecht: Kluvver Academic, 1993:105-111.
7. Barofsky I, Sugarbaker PH. Cancer. In: Spilker B, ed. Quality of life assessment in clinical trials. New York: Raven Press, 1990:23-31.
8. Guyatt GH, Jaeschke R, Feeny DH, et al. Measurements in clinical trials: Choosing the right approach. In: Spilker B, ed. Quality of life and pharmacoeconomics in clinical trials. Philadelphia: Lippincott-Raven, 1996:41-8.
9. Irvine E, Feagan B, Rochon J, et al. A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology 1989;96:804-11.
10. Boyle MH, Torrance GW, Sinclair JC, et al. Economic evaluation of neonatal intensive care of very-Iow-birth-weight infants. N Engl J Med 1983;308:1330-7.
11. Udvarhelyi S, Colditz GA, Rai A, et al. Cost-effectiveness and cost-benefit analyses in the medical literature. Ann Intern Med 1992; 116:238-44.
12. Provenzale D, Shearin M, Phillips-Bute B, et al. Health related quality of life after ileoanal pull-through: Evaluation and assessment of new health status. Gastroenterology 1997;113:714.
13. Dctsky AS, McLaughlin JR, Abrams HB, et al. Quality of life of patients on long-term total parenteral nutrition at home. J Gen Intern Med 1986; 1:26-33.
14. Feeny D, Barr RD, Furlong W, et al. A comprehensive multiattribute system for classifying the health status of survivors of childhood cancer. J Clin Oncol 1992;10:923-8.
15. Stewart AL, Greenfield S, Hays RD, et al. Functional status and well-being of patients with chronic conditions: Results from the Medical Outcomes Study. JAMA 1989;262:907-13.
16. Bergner M, Bobbitt RA, Pollard M, et al. The sickness impact profile: Validation of a health status measure. Med Care 1976; 14:57-67.
17. Testa MA, Anderson RB, Nackley JF, et al. Quality of life and antihypertensive therapy in men: Comparison of captopril and enalopril. N Engl J Med 1993;328:907-13.